Monsanto Company (MON) And TwistDx Begin Field Trials of Rapid Diagnostic Tests for More Efficient Delivery of Biotech Crops
8/4/2009 9:45:20 AM
CAMBRIDGE, England--(BUSINESS WIRE)--TwistDx, a developer of point-of-use nucleic acid diagnostics, announced today that they have made strong progress toward developing rapid, DNA-based field tests with Monsanto Company (NYSE:MON). Monsanto plans to use the tests to enhance the efficiency with which biotechnology crops are delivered across the globe.
comments powered by